C4 Therapeutics, Inc. - COM STK (CCCC)

Q3 2023 Portfolio Holders as of 9/30/2023

Type / Class
Equity / COM STK
Number of holders
81
Total Shares
34.6M
Shares change
+455K
Total reported value, excl. options
$64.3M
Value change
-$105K
Put/Call ratio
1.83
Number of buys
36
Number of sells
-53
Price
$1.86
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.